Search…

Lates News

20/09/2025

The US FDA has approved Merck's blockbuster cancer therapy Keytruda in subcutaneous injection form. Analysts say this marks a significant change in the way this global best-selling cancer immunotherapy is administered, with the potential to improve patient experience and treatment efficiency. This move is also seen as a strategic component of Merck's defense of Keytruda's market share as competition from biosimilars approaches.

Latest

6 m ago

Cryptocurrency custody company BitGo applies for its first initial public offering (IPO).

7 m ago

Mingsheng Company's developing country stock index dropped by 0.4%, narrowing the total weekly gain to just over 1.0%. The MSCI Emerging Markets Currency Index fell by 0.2%, marking its worst single-day performance in the past three weeks, but still showing a cumulative increase of 0.8% so far in September. The Bloomberg Spot Dollar Index rose by 0.2%, with the US dollar receiving support from the quick money.

7 m ago

The MSCI Emerging Markets Stock Index fell by 0.4%, narrowing the cumulative increase for the week to slightly over 1.0%. The MSCI Emerging Markets Currency Index dropped by 0.2%, marking the worst single-day performance in the past three weeks. The Bloomberg Dollar Spot Index rose by 0.2%, supported by quick cash flows into the US dollar.

9 m ago

As of the week ending September 16, speculators on the Intercontinental Exchange (ICE) increased their net long positions in gasoline futures by 10,948 contracts to 118,324 contracts; meanwhile, Brent crude speculators increased their net long positions by 22,593 contracts to 232,171 contracts.

9 m ago

As of the week ending September 16, speculators on the Intercontinental Exchange increased their net long positions in gasoline futures by 10,948 contracts to 118,324 contracts; Brent crude oil speculators increased their net long positions by 22,593 contracts to 232,171 contracts.

See all latest